Verona Pharma plc (VRP.L) (LON:VRP) Shares Cross Below 200-Day Moving Average – Here’s What Happened

Verona Pharma plc (VRP.L) (LON:VRP) shares crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 55 ($0.69) and traded as low as GBX 50 ($0.63). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.69), with a volume of 70,791 shares.

Verona Pharma plc (VRP.L) Stock Up 5.8 %

The business has a 50-day simple moving average of GBX 55 and a 200-day simple moving average of GBX 55. The company has a debt-to-equity ratio of 6.85, a quick ratio of 2.47 and a current ratio of 2.99. The company has a market cap of £228.00 million and a price-to-earnings ratio of -1.68.

About Verona Pharma plc (VRP.L)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.